Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
基本信息
- 批准号:6820659
- 负责人:
- 金额:$ 36.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:blood vessel disordercalcium channelcalcium fluxcoronary arterydisease /disorder proneness /riskelectrophysiologyestrogensfluorescence microscopygender differenceintermolecular interactionpolymerase chain reactionpotassium channelprotein kinase Cswinetestosteronevascular smooth musclevoltage /patch clampvoltage gated channelwestern blottings
项目摘要
DESCRIPTION (provided by applicant): Recent prospective clinical trials have underscored our lack of knowledge with regard to the effect of gender and sex hormones on the coronary vasculature, especially at the cellular/molecular level. Sex hormones exert profound influence on vascular smooth muscle physiology, including proliferation, ion channel activity and channel expression. Coronary smooth muscle (CSM) ion channel activity is central to both regulation of coronary blood flow and progression of vascular disease. We have demonstrated that CSM calcium and potassium channel activities are strongly influenced by gender. This study will determine the mechanism for gender-specific differences in CSM voltage-gated calcium (VGCC) and K channel activity and the consequent effects on intracellular calcium (Cai) regulation and vasoreactivity. The overall hypothesis is that coronary arterial reactivity in males is greater due to a testosterone (TST)-dependent increase in VGCC synthesis and PKC-dependent activity resulting in an enhanced propensity for coronary vasospasm (CVS). Both in vivo (intact, gonadectomized and hormone-replaced swine) and in vitro techniques will be used to determine the role of gender, TST and estrogen (E2) in regulating CSM ion channel activity and coronary arterial reactivity. Aim 1 will determine the mechanism of gender and sex hormone induced changes in VGCC activity and expression using electrophysiology, immunoblot and RT-PCR. As both vasoreactivity and VGCC activity are modulated by PKC, gender and sex hormone effects on PKC regulation of VGCC will also be examined. As the effect of VGCC activity on Cai and contraction is modulated via coupling to K channels and cellular calcium buffering, Aim 2 will determine the effect of sex-specific differences in VGCC activity on Ca-activated (BK) and voltage-dependent K current (Kv) and Cai using simultaneous voltage clamp and microfluorometry. The effect of sex-specific differences in VGCC activity on macro- and microvascular reactivity under both physiological and pathophysiological conditions will be assessed in vitro and in vivo in Aim 3. A model of CVS will be used to assess the role of sex-specific differences in VGCC activity on the progression and severity of vascular disease. The goal of this research is to determine gender-related cellular and molecular differences in CSM as they relate to gender differences in propensity for coronary disease.
描述(由申请人提供):最近的前瞻性临床试验强调了我们缺乏关于性别和性激素对冠状动脉血管系统影响的知识,特别是在细胞/分子水平上。性激素对血管平滑肌的增殖、离子通道活性和通道表达有着重要的影响。冠状动脉平滑肌(CSM)离子通道活性是调节冠状动脉血流和血管疾病进展的中心。我们已经证明,CSM钙和钾通道的活动受到性别的强烈影响。本研究将确定CSM电压门控钙(VGCC)和K通道活性的性别特异性差异的机制,以及对细胞内钙(Cai)调节和血管反应性的影响。总体假设是,由于VGCC合成和PKC依赖性活性的睾酮(TST)依赖性增加导致冠状动脉痉挛(CVS)倾向增强,因此男性冠状动脉反应性更大。将使用体内(完整、性腺切除和去势替代猪)和体外技术来确定性别、TST和雌激素(E2)在调节CSM离子通道活性和冠状动脉反应性中的作用。目的1通过电生理、免疫印迹和RT-PCR等方法,探讨性别和性激素诱导VGCC活性和表达变化的机制。由于血管反应性和VGCC活性均受PKC调节,因此还将检查性别和性激素对VGCC的PKC调节的影响。由于VGCC活性对Cai和收缩的影响是通过与K通道和细胞钙缓冲的偶联来调节的,因此目标2将使用同步电压钳和显微荧光测定法确定VGCC活性的性别特异性差异对Ca激活(BK)和电压依赖性K电流(Kv)和Cai的影响。在目的3中,将在体外和体内评估生理和病理生理条件下VGCC活性的性别特异性差异对大血管和微血管反应性的影响。CVS模型将用于评估VGCC活性的性别特异性差异对血管疾病进展和严重程度的作用。本研究的目的是确定CSM中与性别相关的细胞和分子差异,因为它们与冠心病倾向的性别差异有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS K BOWLES其他文献
DOUGLAS K BOWLES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS K BOWLES', 18)}}的其他基金
Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosis
KCa3.1 在动脉粥样硬化中的细胞特异性作用和治疗潜力
- 批准号:
10586148 - 财政年份:2022
- 资助金额:
$ 36.75万 - 项目类别:
Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosis
KCa3.1 在动脉粥样硬化中的细胞特异性作用和治疗潜力
- 批准号:
10436073 - 财政年份:2022
- 资助金额:
$ 36.75万 - 项目类别:
Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
- 批准号:
6900066 - 财政年份:2005
- 资助金额:
$ 36.75万 - 项目类别:
Ion Channel Regulation Coronary Smooth Muscle Phenotype
离子通道调节冠状动脉平滑肌表型
- 批准号:
7140016 - 财政年份:2005
- 资助金额:
$ 36.75万 - 项目类别:
Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
- 批准号:
7596326 - 财政年份:2005
- 资助金额:
$ 36.75万 - 项目类别:
Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
- 批准号:
7036585 - 财政年份:2005
- 资助金额:
$ 36.75万 - 项目类别:
Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
- 批准号:
7367011 - 财政年份:2005
- 资助金额:
$ 36.75万 - 项目类别:
Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
- 批准号:
7204177 - 财政年份:2005
- 资助金额:
$ 36.75万 - 项目类别:
Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
- 批准号:
6910679 - 财政年份:2004
- 资助金额:
$ 36.75万 - 项目类别:
Coronary ion channels, gender and vasoreactivity
冠状动脉离子通道、性别和血管反应性
- 批准号:
7440355 - 财政年份:2004
- 资助金额:
$ 36.75万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 36.75万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 36.75万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 36.75万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 36.75万 - 项目类别: